
Releases
Park Ha Biological Technology Investors Face September Deadline
September 28 marks the final day for Park Ha Biological Technology investors to seek lead plaintiff status in a pending securities class action. The lawsuit targets the company following allegations that its IPO and subsequent market performance were buoyed by artificial trading and a coordinated social media misinformation scheme.
























